Physiological and pathological aspects of Aβ in iron homeostasis via 5′UTR in the APP mRNA and the therapeutic use of iron-chelators

BMC Neuroscience

Volumn 9, Issue SUPPL. 2, 2008, Pages

  Avramovich Tirosh, Yael ^a   Amit, Tamar ^a   Bar Am, Orit ^a   Weinreb, Orly ^a   Youdim, Moussa B H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 5 (3,4,5 TRIMETHOXYBENZAMIDO)DECAHYDROISOQUINOLINE; ACETYLCYSTEINE; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA SECRETASE; CHELATING AGENT; CLIOQUINOL; CURCUMIN; DEFEROXAMINE; DIMERCAPROL; EPIGALLOCATECHIN GALLATE; ERYTHROMYCIN; FERRITIN; HLA 20; INTERLEUKIN 1; IRON; IRON CHELATING AGENT; MESSENGER RNA; NEUROMODULIN; PAROXETINE; PHENSERINE; SEROTONIN UPTAKE INHIBITOR; TETRATHIOMOLYBDIC ACID; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARINEL; VK 28; XH 1;

5' UNTRANSLATED REGION; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CHELATION THERAPY; CONFERENCE PAPER; DRUG PENETRATION; DRUG POTENCY; DRUG STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; IRON METABOLISM; IRON RESPONSIVE ELEMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RNA TRANSLATION; UNSPECIFIED SIDE EFFECT; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; IRON; IRON CHELATING AGENTS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RNA, MESSENGER;

EID: 57449119060     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-S2-S2     Document Type: Conference Paper

References (66)

1. Bartzokis G Mintz J Sultzer D Marx P Herzberg JS Phelan CK Marder SR In vivo MR evaluation of age-related increases in brain iron AJNR Am J Neuroradiol 1994, 15:1129-1138 8073983
2. Bartzokis G Beckson M Hance DB Marx P Foster JA Marder SR MR evaluation of age-related increase of brain iron in young adult and older normal males Magn Reson Imaging 1997, 15:29-35 9084022
3. Zecca L Youdim MB Riederer P Connor JR Crichton RR Iron, brain ageing and neurodegenerative disorders Nat Rev Neurosci 2004, 5:863-873 15496864
4. Halliwell B Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment Drugs Aging 2001, 18:685-716 11599635
5. Sayre LM Smith MA Perry G Chemistry and biochemistry of oxidative stress in neurodegenerative disease Curr Med Chem 2001, 8:721-738 11375746
6. Lovell MA Robertson JD Teesdale WJ Campbell JL Markesbery WR Copper, iron and zinc in Alzheimer's disease senile plaques J Neurol Sci 1998, 158:47-52 9667777
7. Pinero DJ Hu J Connor JR Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains Cell Mol Biol 2000, 46:761-776 10875438
8. Smith MA Hirai K Hsiao K Pappolla MA Harris PL Siedlak SL Tabaton M Perry G Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress J Neurochem 1998, 70:2212-2215 9572310
9. Moreira PI Siedlak SL Aliev G Zhu X Cash AD Smith MA Perry G Oxidative stress mechanisms and potential therapeutics in Alzheimer disease J Neural Transm 2005, 112:921-932 15583960
10. Castellani RJ Honda K Zhu X Cash AD Nunomura A Perry G Smith MA Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease Ageing Res Rev 2004, 3:319-326 15231239
11. Honda K Casadesus G Petersen RB Perry G Smith MA Oxidative stress and redox-active iron in Alzheimer's disease Ann N Y Acad Sci 2004, 1012:179-182 15105265
12. Casadesus G Smith MA Zhu X Aliev G Cash AD Honda K Petersen RB Perry G Alzheimer disease: Evidence for a central pathogenic role of iron-mediated reactive oxygen species J Alzheimers Dis 2004, 6:165-169 15096700
13. Takeda A Smith MA Avila J Nunomura A Siedlak SL Zhu X Perry G Sayre LM In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification J Neurochem 2000, 75:1234-1241 10936206
14. Shimohama S Tanino H Kawakami N Okamura N Kodama H Yamaguchi T Hayakawa T Nunomura A Chiba S Perry G et al. Activation of NADPH oxidase in Alzheimer's disease brains Biochem Biophys Res Commun 2000, 273:5-9 10873554
15. Schipper HM Heme oxygenase-1: Role in brain aging and neurodegeneration Exp Gerontol 2000, 35:821-830 11053673
16. Honda K Smith MA Zhu X Baus D Merrick WC Tartakoff AM Hattier T Harris PL Siedlak SL Fujioka H et al. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron J Biol Chem 2005, 280:20978-20986 15767256
17. Connor JR Menzies SL St Martin SM Mufson EJ A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains J Neurosci Res 1992, 31:75-83 1613823
18. Yamada T Tsujioka Y Taguchi J Takahashi M Tsuboi Y Moroo I Yang J Jefferies WA Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer's disease Brain Res 1999, 845:1-5 10529437
19. Grundke-Iqbal I Fleming J Tung YC Lassmann H Iqbal K Joshi JG Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia Acta Neuropathol 1990, 81:105-110 2082650
20. Moalem S Percy ME Andrews DF Kruck TP Wong S Dalton AJ Mehta P Fedor B Warren AC Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 2000, 93:58-66 10861683
21. Berlin D Chong G Chertkow H Bergman H Phillips NA Schipper HM Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI Neurobiol Aging 2004, 25:465-474 15013567
22. Bush AI The metallobiology of Alzheimer's disease Trends Neurosci 2003, 26:207-214 12689772
23. House E Collingwood J Khan A Korchazkina O Berthon G Exley C Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease J Alzheimers Dis 2004, 6:291-301 15201484
24. Yamamoto A Shin RW Hasegawa K Naiki H Sato H Yoshimasu F Kitamoto T Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: Implications in the formation of neurofibrillary tangles of Alzheimer's disease J Neurochem 2002, 82:1137-1147 12358761
25. Rogers JT Randall JD Cahill CM Eder PS Huang X Gunshin H Leiter L McPhee J Sarang SS Utsuki T et al. An iron-responsive element type II in the 57prime;-untranslated region of the Alzheimer's amyloid precursor protein transcript J Biol Chem 2002, 277:45518-45528 12198135
26. Rogers JT Leiter LM McPhee J Cahill CM Zhan SS Potter H Nilsson LN Translation of the alzheimer amyloid precursor protein mRNA is up-regulated by interleukin-1 through 5′-untranslated region sequences J Biol Chem 1999, 274:6421-6431 10037734
27. Atwood CS Obrenovich ME Liu T Chan H Perry G Smith MA Martins RN Amyloid-beta: A chameleon walAing in two worlds: a review of the trophic and toxic properties of amyloid-beta Brain Res Brain Res Rev 2003, 43:1-16 14499458
28. Nunomura A Perry G Aliev G Hirai K Takeda A Balraj EK Jones PK Ghanbari H Wataya T Shimohama S et al. Oxidative damage is the earliest event in Alzheimer disease J Neuropathol Exp Neurol 2001, 60:759-767 11487050
29. Moechars D Dewachter I Lorent K Reverse D Baekelandt V Naidu A Tesseur I Spittaels K Haute CV Checler F et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain J Biol Chem 1999, 274:6483-6492 10037741
30. Misonou H Morishima-Kawashima M Ihara Y Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells Biochemistry 2000, 39:6951-6959 10841777
31. Paola D Domenicotti C Nitti M Vitali A Borghi R Cottalasso D Zaccheo D Odetti P Strocchi P Marinari UM et al. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells Biochem Biophys Res Commun 2000, 268:642-646 10679257
32. Zhang L Zhao B Yew DT Kusiak JW Roth GS Processing of Alzheimer's amyloid precursor protein during H2O2-induced apoptosis in human neuronal cells Biochem Biophys Res Commun 1997, 235:845-848 9207249
33. Abe K St George-Hyslop PH Tanzi RE Kogure K Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells Neurosci Lett 1991, 125:169-171 1652710
34. Shi J Xiang Y Simpkins JW Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells Brain Res 1997, 772:247-251 9406980
35. Shi J Perry G Smith MA Friedland RP Vascular abnormalities: The insidious pathogenesis of Alzheimer's disease Neurobiol Aging 2000, 21:357-361 10867221
36. Tamagno E Bardini P Obbili A Vitali A Borghi R Zaccheo D Pronzato MA Danni O Smith MA Perry G et al. Oxidative stress increases expression and activity of BACE in NT2 neurons Neurobiol Dis 2002, 10:279-288 12270690
37. Tamagno E Parola M Bardini P Piccini A Borghi R Guglielmotto M Santoro G Davit A Danni O Smith MA et al. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways J Neurochem 2005, 92:628-636 15659232
38. Rogers JT Lahiri DK Metal and inflammatory targets for Alzheimer's disease Curr Drug Targets 2004, 5:535-551 15270200
39. Robinson SR Bishop GM Abeta as a bioflocculant: Implication for the amyloid hypothesis of Alzheimer's disease Neurobiol Aging 2002, 23:1051-1072 12470802
40. Zou K Gong JS Yanagisawa K Michikawa M A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage J Neurosci 2002, 22:4833-4841 12077180
41. Bishop GM Robinson SR The amyloid paradox: Amyloid-beta-metal complexes can be neurotoxic and neuroprotective Brain Pathol 2004, 14:448-452 15605992
42. Nakamura M Shishido N Nunomura A Smith MA Perry G Hayashi Y Nakayama K Hayashi T Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron Biochemistry 2007, 46:12737-12743 17929832
43. Crapper McLachlan DR Dalton AJ Kruck TP Bell MY Smith WL Kalow W Andrews DF Intramuscular desferrioxamine in patients with Alzheimer's disease Lancet 1991, 337:1304-1308 1674295
44. Cherny RA Atwood CS Xilinas ME Gray DN Jones WD McLean CA Barnham KJ Volitakis I Fraser FW Kim Y et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice Neuron 2001, 30:665-676 11430801
45. Ritchie CW Bush AI Mackinnon A Macfarlane S Mastwyk M MacGregor L Kiers L Cherny R Li QX Tammer A et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: A pilot phase 2 clinical trial Arch Neurol 2003, 60:1685-1691 14676042
46. Rogers JT Randall JD Eder PS Huang X Bush AI Tanzi RE Venti A Payton SM Giordano T Nagano S et al. Alzheimer's disease drug discovery targeted to the APP mRNA 5′untranslated region J Mol Neurosci 2002, 19:77-82 12212798
47. Payton S Cahill CM Randall JD Gullans SR Rogers JT Drug discovery targeted to the Alzheimer's APP mRNA 5′-untranslated region: The action of paroxetine and dimercaptopropanol J Mol Neurosci 2003, 20:267-275 14501007
48. Dedeoglu A Cormier K Payton S Tseitlin KA Kremsky JN Lai L Li X Moir RD Tanzi RE Bush AI et al. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis Exp Gerontol 2004, 39:1641-1649 15582280
49. Ben-Shachar D Kahana N Kampel V Warshawsky A Youdim MBH Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats Neuropharmacology 2004, 46:254-263 14680763
50. Zheng H Weiner LM Bar-Am O Epsztejn S Cabantchik ZI Warshawsky A Youdim MB Fridkin M Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases Bioorg Med Chem 2005, 13:773-783 15653345
51. Avramovich-Tirosh Y Amit T Bar-Am O Zheng H Fridkin M Youdim MBH Therapeutic targets and potential of the novel brain-permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease J Neurochem 2007, 100:490-502 17144902
52. Guo Q Zhao B Li M Shen S Xin W Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes Biochimica et Biophysica Acta 1996, 1304:210-222 8982267
53. Kumamoto M Sonda T Nagayama K Tabata M Effects of pH and metal ions on antioxidative activities of catechins Biosci Biotechnol Biochem 2001, 65:126-132 11272815
54. Baum L Ng A Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models J Alzheimers Dis 2004, 6:367-377 443-369. 15345806
55. Mandel S Weinreb O Reznichenko L Kalfon L Amit T Green tea catechins as brain-permeable, non toxic iron chelators to 'iron out iron' from the brain J Neural Transm 2006, 249-257 16897606
56. Reznichenko L Amit T Zheng H Avramovich-Tirosh Y Youdim MB Weinreb O Mandel S Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease J Neurochem 2006, 97:527-536 16539659
57. Rezai-Zadeh K Shytle D Sun N Mori T Hou H Jeanniton D Ehrhart J Townsend K Zeng J Morgan D et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice J Neurosci 2005, 25:8807-8814 16177050
58. Avramovich-Tirosh Y Reznichenko L Amit T Zheng H Fridkin M Mandel S Youdim MBH Neurorescue activity, APP regulation and amyloid- peptide reduction by novel multi-functional brain permeable iron- chelator- antioxidants, M-30 and green tea polyphenol, EGCG Curr Alzheimer Res 2007, 4:403-411 17908043
59. Bandyopadhyay S Ni J Ruggiero A Walshe K Rogers MS Chattopadhyay N Glicksman MA Rogers JT A high-throughput drug screen targeted to the 5′untranslated region of Alzheimer amyloid precursor protein mRNA J Biomol Screen 2006, 11:469-480 16928984
60. Copani A Condorelli F Caruso A Vancheri C Sala A Giuffrida Stella AM Canonico PL Nicoletti F Sortino MA Mitotic signaling by beta-amyloid causes neuronal death FASEB J 1999, 13:2225-2234 10593870
61. Giovanni A Wirtz-Brugger F Keramaris E Slack R Park DS Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F × DP, in B-amyloid-induced neuronal death J Biol Chem 1999, 274:19011-19016 10383401
62. Wu Q Combs C Cannady SB Geldmacher DS Herrup K Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons Neurobiol Aging 2000, 21:797-806 11124423
63. Reznichenko L Amit T Youdim MB Mandel S Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth J Neurochem 2005, 93:1157-1167 15934936
64. Friedlich AL Tanzi RE Rogers JT The 5′-untranslated region of Parkinson's disease alpha-synuclein messenger RNA contains a predicted iron responsive element Mol Psychiatry 2007, 12:222-223 17325711
65. Tucker S Ahl M Bush A Westaway D Huang X Rogers JT Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer's APP 5′ untranslated region Curr Alzheimer Res 2005, 2:249-254 15974925
66. Shaw KT Utsuki T Rogers J Yu QS Sambamurti K Brossi A Ge YW Lahiri DK Greig NH Phenserine regulates translation of beta-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development Proc Natl Acad Sci USA 2001, 98:7605-7610 34715 11404470